Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

2.

Efficacy and safety of linezolid in treating gram-positive bacterial infection in the elderly: a retrospective study.

Zhou ZY, Zhao XQ, Shan BZ, Zhu J, Zhang X, Tian QF, Chen DF, Jia TH.

Indian J Microbiol. 2014 Mar;54(1):104-7. doi: 10.1007/s12088-013-0422-z. Epub 2013 Aug 3.

3.

Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.

Niwa T, Suzuki A, Sakakibara S, Kasahara S, Yasuda M, Fukao A, Matsuura K, Goto C, Murakami N, Itoh Y.

Clin Ther. 2009 Oct;31(10):2126-33. doi: 10.1016/j.clinthera.2009.10.017.

PMID:
19922883
4.

[Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].

Tang L, Fang J, Wang SN, Weng XH, Li JJ, Shang EN.

Zhonghua Er Ke Za Zhi. 2016 Sep;54(9):686-91. doi: 10.3760/cma.j.issn.0578-1310.2016.09.011. Chinese.

PMID:
27596084
5.

Efficacy and safety of linezolid in liver transplant patients.

Radunz S, Juntermanns B, Kaiser GM, Treckmann J, Mathe Z, Paul A, Saner FH.

Transpl Infect Dis. 2011 Aug;13(4):353-8. doi: 10.1111/j.1399-3062.2011.00617.x. Epub 2011 Feb 28.

PMID:
21355969
6.

High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid.

Zhang YM, Yu W, Zhou N, Li JZ, Xu LC, Xie ZY, Lu YF, Li LJ.

Hepatobiliary Pancreat Dis Int. 2015 Jun;14(3):287-92.

PMID:
26063030
7.

The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.

Ichie T, Suzuki D, Yasui K, Takahashi H, Matsuda M, Hayashi H, Sugiura Y, Sugiyama T.

J Clin Pharm Ther. 2015 Jun;40(3):279-84. doi: 10.1111/jcpt.12260. Epub 2015 Mar 2.

PMID:
25732525
8.

Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.

Hirano R, Sakamoto Y, Tachibana N, Ohnishi M.

Int J Clin Pharm. 2014 Aug;36(4):795-9. doi: 10.1007/s11096-014-9961-6. Epub 2014 Jun 10.

PMID:
24913359
9.

Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery.

Ikuta S, Tanimura K, Yasui C, Aihara T, Yoshie H, Iida H, Beppu N, Kurimoto A, Yanagi H, Mitsunobu M, Yamanaka N.

J Infect Chemother. 2011 Jun;17(3):388-91. doi: 10.1007/s10156-010-0188-8. Epub 2010 Dec 16.

PMID:
21161560
10.

Risk factors for thrombocytopenia in adult chinese patients receiving linezolid therapy.

Chen C, Guo DH, Cao X, Cai Y, Xu Y, Zhu M, Ma L.

Curr Ther Res Clin Exp. 2012 Dec;73(6):195-206. doi: 10.1016/j.curtheres.2012.07.002.

11.

Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Tessier JM, Puzio T, Young A, Wolfe L, Han J, Duane TM.

Surg Infect (Larchmt). 2015 Aug;16(4):361-7. doi: 10.1089/sur.2013.190. Epub 2015 May 28.

PMID:
26207396
12.

High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.

Wu VC, Wang YT, Wang CY, Tsai IJ, Wu KD, Hwang JJ, Hsueh PR.

Clin Infect Dis. 2006 Jan 1;42(1):66-72. Epub 2005 Nov 18.

PMID:
16323094
13.

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy.

Takahashi Y, Takesue Y, Nakajima K, Ichiki K, Tsuchida T, Tatsumi S, Ishihara M, Ikeuchi H, Uchino M.

J Infect Chemother. 2011 Jun;17(3):382-7. doi: 10.1007/s10156-010-0182-1. Epub 2010 Dec 3.

PMID:
21127934
14.

Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.

Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB; Linezolid Pediatric Study Group.

Pediatr Infect Dis J. 2003 Aug;22(8):677-86.

PMID:
12913766
15.

Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia.

Smith PF, Birmingham MC, Noskin GA, Meagher AK, Forrest A, Rayner CR, Schentag JJ.

Ann Oncol. 2003 May;14(5):795-801.

PMID:
12702536
16.
17.

Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.

PMID:
11827558
18.

[Clinical analysis of 102 blood disease patients with gram positive cocci infection treated with Linezolid].

Guan J, Fu R, Ruan EB, Liang Y, Qu W, Wang GJ, Wang XM, Liu H, Wu YH, Song J, Wang HQ, Xing LM, Shao ZH.

Zhonghua Xue Ye Xue Za Zhi. 2010 Aug;31(8):527-30. Chinese.

PMID:
21122331
19.

[Retrospective analysis of the Gram-positive bacteria-infected cases in the Department of Hematology].

Jing Y, Bo J, Zhao Y, Li HH, Wang SH, Huang WR, Wang QS.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1291-5. doi: 10.7534/j.issn.1009-2137.2013.05.041. Chinese.

PMID:
24156452
20.

Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.

Dong HY, Xie J, Chen LH, Wang TT, Zhao YR, Dong YL.

Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):1029-35. doi: 10.1007/s10096-013-2041-3. Epub 2014 Feb 12.

PMID:
24515096

Supplemental Content

Support Center